Like Cipla in pharma space: Vivek Mahajan, Aditya Birla Money

Vivek Mahajan, Head-Research, Aditya Birla Money, in a chat with ET Now talks about pharma stocks.

What is the take on any pharmaceutical space?

Of late, what we have seen is that corporate governance has been a big issue. The large cap companies are still better off, mid cap companies you could be having lot of issues. So it will make more sense to stick with the large cap companies. The stocks we like in pharma space, Cipla and Aurobindo Pharma. These could offer an upside of something like 15-20% in next year as well.